Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds.

Pharand C, Goldman R, Fan C, Chow M, Kluger J.

Pacing Clin Electrophysiol. 1996 Jan;19(1):82-9.

PMID:
8848382
2.

Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.

Dougherty AH.

Curr Opin Cardiol. 1996 Jan;11(1):2-8. Review.

PMID:
8664528
3.

Effect of drugs on defibrillation capacity.

Dopp AL, Miller JM, Tisdale JE.

Drugs. 2008;68(5):607-30. Review.

PMID:
18370441
4.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
5.

Energy levels for defibrillation: what is of real clinical importance?

Fotuhi PC, Epstein AE, Ideker RE.

Am J Cardiol. 1999 Mar 11;83(5B):24D-33D. Review.

PMID:
10089836
6.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
7.

Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions.

Marchlinski FE, Zado ES, Deely MP, Saligan J, Ashar M, Nayak H.

Am J Cardiol. 1999 Nov 4;84(9A):69R-75R. Review.

PMID:
10568663
8.

Defibrillation threshold testing and neurologic outcome.

Karaoğuz R.

Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:47-9. Review.

9.

Combining antiarrhythmic drugs and implantable devices therapy: benefits and outcome.

Santini M, Pandozi C, Ricci R.

J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:65-8. Review.

PMID:
10590491
10.

New technologies of internal defibrillation.

Dosdall DJ, Ideker RE.

J Interv Card Electrophysiol. 2005 Aug;13 Suppl 1:67-70. Review.

PMID:
16133858
11.

[Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].

Fauchier JP, Babuty D, Rouesnel P, Cosnay P, Estepo J.

Arch Mal Coeur Vaiss. 1991 Apr;84(4):553-60. Review. French.

PMID:
1712193
12.

Comparison of atrial ventricular fibrillation and defibrillation.

Ideker RE, Cooper RA, Walcott KT.

Pacing Clin Electrophysiol. 1994 May;17(5 Pt 2):1034-42. Review. No abstract available.

PMID:
7518591
13.

Accepted, controversial, and speculative aspects of ventricular defibrillation.

Crampton R.

Prog Cardiovasc Dis. 1980 Nov-Dec;23(3):167-86. Review. No abstract available.

PMID:
7001540
14.

The structural-functional basis of spontaneous ventricular defibrillation.

Manoach M, Basat MB.

Int J Cardiol. 1990 Feb;26(2):129-36. Review. No abstract available.

PMID:
2406207
15.

[Pharmacology of atrio-ventricular conduction].

Duchêne-Marullaz P, Kantelip JP.

Actual Pharmacol (Paris). 1981;33:105-30. Review. French. No abstract available.

PMID:
6116379
16.

Moricizine.

Clyne CA, Estes NA 3rd, Wang PJ.

N Engl J Med. 1992 Jul 23;327(4):255-60. Review. No abstract available.

PMID:
1614466
17.

Cardiac innervation: anatomic and pharmacologic relations.

James TN.

Bull N Y Acad Med. 1967 Dec;43(12):1041-86. Review. No abstract available.

Supplemental Content

Support Center